Down-Regulation of TGF-β Expression Sensitizes the Resistance of Hepatocellular Carcinoma Cells to Sorafenib

PURPOSE: Sorafenib, a multikinase inhibitor, is the standard therapy for patients with advanced-stage hepatocellular carcinoma (HCC). However, resistance develops to the treatment, therefore, we tried to unravel the underlying mechanism in the resistance of HCC cells to sorafenib via the development...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Yonsei Med J
Egile Nagusiak: Kang, Dongxu, Han, Zhezhu, Oh, Geun-Hyeok, Joo, Yeonsoo, Choi, Hye Jin, Song, Jae J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Yonsei University College of Medicine 2017
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5552643/
https://ncbi.nlm.nih.gov/pubmed/28792132
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2017.58.5.899
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak